193 related articles for article (PubMed ID: 26219901)
1. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.
Erturk K; Tastekin D; Serilmez M; Bilgin E; Bozbey HU; Vatansever S
Tumour Biol; 2016 Jan; 37(1):405-12. PubMed ID: 26219901
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of Serum Vascular Endothelial Growth Factor, Pigment Epithelium-Derived Factor, Tumor Necrosis Factor Alpha, and Progranulin Levels in Patients with Gastric Cancer and Gastric Precancerous Lesions.
Aksoy EK; Akpınar MY; Doğan Ö; Göktaş Z; Sapmaz FP; Şimşek GG; Uzman M; Nazlıgül Y
J Gastrointest Cancer; 2019 Sep; 50(3):537-542. PubMed ID: 31089953
[TBL] [Abstract][Full Text] [Related]
3. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.
Kern P; Hemmer CJ; Van Damme J; Gruss HJ; Dietrich M
Am J Med; 1989 Aug; 87(2):139-43. PubMed ID: 2667356
[TBL] [Abstract][Full Text] [Related]
4. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
[TBL] [Abstract][Full Text] [Related]
5. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?
Erturk K; Tastekin D; Bilgin E; Serilmez M; Bozbey HU; Sakar B
Biomed Pharmacother; 2016 Feb; 77():86-91. PubMed ID: 26796270
[TBL] [Abstract][Full Text] [Related]
6. IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.
Ma Y; Ren Y; Dai ZJ; Wu CJ; Ji YH; Xu J
Adv Clin Exp Med; 2017; 26(3):421-426. PubMed ID: 28791816
[TBL] [Abstract][Full Text] [Related]
7. Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer.
Guo L; Ou JL; Zhang T; Ma L; Qu LF
Tumour Biol; 2015 Nov; 36(11):8853-60. PubMed ID: 26069103
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-17 levels can be diagnostic for gastric cancer.
Karabulut M; Usul Afsar C; Serimez M; Karabulut S
J BUON; 2019; 24(4):1601-1609. PubMed ID: 31646815
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
10. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer.
Szaflarska A; Szczepanik A; Siedlar M; Czupryna A; Sierzega M; Popiela T; Zembala M
Anticancer Res; 2009 Dec; 29(12):5005-12. PubMed ID: 20044609
[TBL] [Abstract][Full Text] [Related]
11. Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.
Xue T; Yang J; Song P; Zhou G
J BUON; 2019; 24(1):215-220. PubMed ID: 30941972
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome.
Tripsianis G; Papadopoulou E; Anagnostopoulos K; Botaitis S; Katotomichelakis M; Romanidis K; Kontomanolis E; Tentes I; Kortsaris A
Neoplasma; 2014; 61(2):205-12. PubMed ID: 24299316
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer.
Forones NM; Mandowsky SV; Lourenço LG
Hepatogastroenterology; 2001; 48(40):1199-201. PubMed ID: 11490833
[TBL] [Abstract][Full Text] [Related]
14. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
Atwa MA; Youssef N; Bayoumy NM
Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
[TBL] [Abstract][Full Text] [Related]
15. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic role of serum interleukin-18 in gastric cancer patients.
Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
[TBL] [Abstract][Full Text] [Related]
17. Serum interleukin-33 levels in patients with gastric cancer.
Sun P; Ben Q; Tu S; Dong W; Qi X; Wu Y
Dig Dis Sci; 2011 Dec; 56(12):3596-601. PubMed ID: 21643739
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor.
Ashizawa T; Okada R; Suzuki Y; Takagi M; Yamazaki T; Sumi T; Aoki T; Ohnuma S; Aoki T
Gastric Cancer; 2005; 8(2):124-31. PubMed ID: 15864720
[TBL] [Abstract][Full Text] [Related]
19. Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer.
de Oliveira JG; Rossi AF; Nizato DM; Cadamuro AC; Jorge YC; Valsechi MC; Venâncio LP; Rahal P; Pavarino ÉC; Goloni-Bertollo EM; Silva AE
Tumour Biol; 2015 Dec; 36(12):9159-70. PubMed ID: 26088449
[TBL] [Abstract][Full Text] [Related]
20. Serum level of interleukin-35 as a potential prognostic factor for gastric cancer.
Gu JH; Wang XG; Wang LQ; Zhou LN; Tang M; Li P; Wu XY; Chen MB; Zhang Y
Asia Pac J Clin Oncol; 2021 Feb; 17(1):52-59. PubMed ID: 33044052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]